Home/Filings/4/0001576885-24-000036
4//SEC Filing

Doherty James J. 4

Accession 0001576885-24-000036

CIK 0001576885other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 5:02 PM ET

Size

5.6 KB

Accession

0001576885-24-000036

Insider Transaction Report

Form 4
Period: 2024-02-01
Doherty James J.
President and CDO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-02-01+601,000601,000 total
    Exercise: $3.11Exp: 2034-02-01Common Stock (601,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on February 1, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Issuer

Acumen Pharmaceuticals, Inc.

CIK 0001576885

Entity typeother

Related Parties

1
  • filerCIK 0002009718

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 5:02 PM ET
Size
5.6 KB